检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors.

Yuxiang Ma,Jinhui Xue,Yuanyuan Zhao,Yang Zhang,Yan Huang,Yunpeng Yang,Wenfeng Fang,Ye Guo,Qun Li,Xiaoxiao Ge, Jie Sun,Bangyong Zhang,Yuhan Zhang,Jinyuan Xiao,Li Zhang,Hongyun Zhao

Journal for immunotherapy of cancer（2023）

引用 0|浏览9
暂无评分
摘要
NCT03733951 .
更多
查看译文
关键词
Clinical Trials as Topic, Antibodies, Neoplasm, Immunohistochemistry, Tumor Biomarkers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要